Clinical Significance of Topoisomerase-II Expression in Patients with Non-Small Cell Lung Cancer Treated with Amrubicin

被引：0
|
作者：
Sakurai, R. [1 ]
Kaira, K. [2 ]
Miura, Y. [1 ]
Tomizawa, Y. [3 ]
Tsukagoshi, Y. [1 ]
Masuda, T. [1 ]
Kasahara, N. [1 ]
Sunaga, N. [4 ]
Saito, R. [3 ]
Hisada, T. [1 ]
机构：
[1] Gunma Univ Hosp, Div Allergy & Resp Med, Maebashi, Gunma, Japan
[2] Gunma Univ, Grad Sch Med, Dept Oncol Clin Dev, Maebashi, Gunma, Japan
[3] Natl Hosp Org Shibukawa Med Ctr, Div Resp Med, Shibukawa, Japan
[4] Gunma Univ Hosp, Oncol Ctr, Maebashi, Gunma, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
topoisomerase-II; Amrubicin; non-small cell lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-027
引用
收藏
页码：S2078 / S2078
页数：1
相关论文
共 50 条
  • [31] Expression and clinical significance of SYNE3 in non-small cell lung cancer
    Wu, Yunxi
    Chen, Dehe
    Luo, Yu
    Wang, Jun
    Gong, Haiying
    Li, Junhua
    Jiang, Li
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (09): : 4436 - 4449
  • [32] Expression and clinical significance of HCCS1 in non-small cell lung cancer
    Shen Xiao-Yong
    Lin Zhi-Feng
    Lu Fan-zhen
    Ruan Zhen
    Zhen Jian
    Huang Hai-long
    Ju Chao-qiang
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2012, 16 (04): : 328 - 331
  • [33] Expression patterns and clinical significance of estrogen receptor in non-small cell lung cancer
    Castellanos, Mario R.
    Fanous, Ereeny
    Thaker, Rina
    Flory, Michael J.
    Seetharamu, Nagashree
    Dhar, Meekoo
    Starr, Adam
    Strange, Theodore J.
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 241
  • [34] Expression and Clinical Significance of CMTM6 in Non-Small Cell Lung Cancer
    He, S.
    Wang, Y.
    He, X.
    Ma, H.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S337 - S337
  • [35] Clinical Significance of Prostate Stem Cell Antigen Expression in Non-small Cell Lung Cancer
    Kawaguchi, Takeshi
    Sho, Masayuki
    Tojo, Takashi
    Yamato, Ichiro
    Nomi, Takeo
    Hotta, Kiyohiko
    Hamada, Kaoru
    Suzaki, Yasue
    Sugiura, Shigeki
    Kushibe, Keiji
    Nakajima, Yoshiyuki
    Taniguchi, Shigeki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (04) : 319 - 326
  • [36] EXPRESSION OF HEPARANASE AND ITS CLINICAL SIGNIFICANCE IN HUMAN NON-SMALL CELL LUNG CANCER
    韩昱晨
    李姝玉
    于敏
    谷雨妹
    张四洋
    IRIS Pecker
    王恩华
    邱雪杉
    ChineseJournalofCancerResearch, 2005, (03) : 207 - 212
  • [37] Clinical significance of ALKBH4 expression in non-small cell lung cancer
    Aoki, Masaya
    Ueda, Kazuhiro
    Kamimura, Go
    Iwamoto, Yoshiyuki
    Ikehata, Mizuki
    Tabata, Keisuke
    Sakagami, Yuri
    Morizono, Shoichiro
    Tokunaga, Takuya
    Umehara, Tadashi
    Harada-Takeda, Aya
    Maeda, Koki
    Nagata, Toshiyuki
    Kariatsumari, Kota
    Furukawa, Tatsuhiko
    Tsujikawa, Kazutake
    Sato, Masami
    TRANSLATIONAL CANCER RESEARCH, 2022, 11 (07) : 2040 - 2049
  • [38] Expression of β-catenin and OPG in human non-small cell lung cancer and their clinical significance
    Li, Zhen-Zhen
    Zhang, Shi-Min
    Yang, Chun-Xu
    Sun, Shao-Xing
    Yang, Jie
    Tian, Xiao-Li
    Xiong, Fei
    Wang, Sheng
    Xie, Cong-Hua
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (07): : 7244 - 7254
  • [39] A phase II trial of combination chemotherapy with irinotecan and amrubicin in pretreated patients with non-small cell lung cancer
    Segawa, Y.
    Nogami, N.
    Shinkai, T.
    Kiura, K.
    Tabata, M.
    Takigawa, N.
    Hotta, K.
    Shibayama, T.
    Ueoka, H.
    Tanimoto, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [40] Phase II Study of Weekly Amrubicin for Refractory or Relapsed Non-small Cell Lung Cancer
    Kitagawa, Chiyoe
    Iwasaku, Masahiro
    Kogure, Yoshihito
    Ando, Masahiko
    Yoshioka, Hiroshige
    Nishiyama, Akihiro
    Watanabe, Naoki
    Kunimasa, Kei
    Tsubouchi, Kazuya
    Oka, Saori
    Saka, Hideo
    IN VIVO, 2019, 33 (01): : 163 - 166
12345